https://www.buzzfeednews.com/article/stephaniemlee/ivermecti...
https://gidmk.medium.com/is-ivermectin-for-covid-19-based-on...
Not to even mention that the only realistic effect it would have is blunting the effects of IL-6. There’s better options for antagonizing IL-6 with less of a side effect profile, specifically tocilizumab and sarilumab.
If you refer to blocking nuclear import, ORF6 in SARS-CoV and other sarbecoviruses already does that to begin with. Adding SARS-CoV ORF6 to a MHV model actually made it more pathogenic, so there is little benefit to not blocking nuclear import.
Here are some associated material on the topic:
https://journals.asm.org/doi/10.1128/JVI.01012-07
https://journals.asm.org/doi/10.1128/jvi.01308-07
https://journals.asm.org/doi/full/10.1128/JVI.79.17.11335-11...
https://www.sciencedirect.com/science/article/pii/S221112472...